It all comes down to making money… Early exits are an important part of the financial reward needed to turn a very risky portfolio of angel investments into an asset that provides an excellent risk/reward profile for you, the investor. Not all companies are primed for an early acquisition, so it’s important to understand before you invest whether your are jumping into a situation that is conducive to an early exit.
- Clinical Trial Confirms GammaTile Superior Tumor Control
- 2025 Brutal Biotech Investment Climate
- Delta Development Team – Introducing BloodCOMM Premium
- Special Operations Forces Blood Cooler from Delta Development
- UACI startup alumni Reglagene making impressive strides in brain cancer treatment
- Reglagene RGN6024 Cover Story August 2025 Molecular Cancer Therapeutics
- Calls for More Angel Investing
- Takes a Licking and Keeps on Ticking
- Ventura County firefighters make history with in-the-field blood transfusions
- FireRescue1’s “3 Things We’re Watching at FDIC 2025